BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

556 related articles for article (PubMed ID: 29458779)

  • 1. Systemic treatment in adult uterine sarcomas.
    Desar IME; Ottevanger PB; Benson C; van der Graaf WTA
    Crit Rev Oncol Hematol; 2018 Feb; 122():10-20. PubMed ID: 29458779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in the treatment of sarcomas in gynecology.
    Lange SS; Novetsky AP; Powell MA
    Discov Med; 2014 Sep; 18(98):133-40. PubMed ID: 25227754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome and prognosis in uterine sarcoma and malignant mixed Mullerian tumor.
    Burghaus S; Halmen S; Gass P; Mehlhorn G; Schrauder MG; Lux MP; Renner SP; Beckmann MW; Hein A; Thiel FC
    Arch Gynecol Obstet; 2016 Aug; 294(2):343-51. PubMed ID: 26711836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uterine sarcomas 2013.
    Sutton G
    Gynecol Oncol; 2013 Jul; 130(1):3-5. PubMed ID: 23769183
    [No Abstract]   [Full Text] [Related]  

  • 5. Low-Grade Endometrial Stromal Sarcoma - a Review.
    Thiel FC; Halmen S
    Oncol Res Treat; 2018; 41(11):687-692. PubMed ID: 30317238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical management of uterine sarcomas.
    Amant F; Coosemans A; Debiec-Rychter M; Timmerman D; Vergote I
    Lancet Oncol; 2009 Dec; 10(12):1188-98. PubMed ID: 19959075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uterine sarcoma Part II-Uterine endometrial stromal sarcoma: The TAG systematic review.
    Horng HC; Wen KC; Wang PH; Chen YJ; Yen MS; Ng HT;
    Taiwan J Obstet Gynecol; 2016 Aug; 55(4):472-9. PubMed ID: 27590366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of clinicopathologic prognostic factors for 157 uterine sarcomas and evaluation of a grading score validated for soft tissue sarcoma.
    Pautier P; Genestie C; Rey A; Morice P; Roche B; Lhommé C; Haie-Meder C; Duvillard P
    Cancer; 2000 Mar; 88(6):1425-31. PubMed ID: 10717626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Localized high grade endometrial stromal sarcoma and localized undifferentiated uterine sarcoma: a retrospective series of the French Sarcoma Group.
    Meurer M; Floquet A; Ray-Coquard I; Bertucci F; Auriche M; Cordoba A; Piperno-Neumann S; Salas S; Delannes M; Chevalier T; Italiano A; Blay JY; Mancini J; Pautier P; Duffaud F
    Int J Gynecol Cancer; 2019 May; 29(4):691-698. PubMed ID: 30772825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uterine sarcoma: clinicopathological characteristics, treatment and outcome in Iran.
    Ghaemmaghami F; Karimi-Zarchi M; Gilani MM; Mousavi A; Behtash N; Ghasemi M
    Asian Pac J Cancer Prev; 2008; 9(3):421-6. PubMed ID: 18990014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diagnosis of uterine sarcomas and rare uterine mesenchymal tumours with malignant potential. Guidelines of the French Sarcoma Group and Rare Gynaecological Tumours].
    Croce S; Devouassoux-Shisheboran M; Pautier P; Ray-Coquard I; Treilleux I; Neuville A; Arnould L; Just PA; Le Frere Belda MA; Averous G; Leroux A; Bataillon G; Mery E; Loussouarn D; Weinbreck N; Le Guellec S; Mishellany F; Morice P; Guyon F; Genestie C
    Bull Cancer; 2024 Jan; 111(1):97-116. PubMed ID: 37806863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical outcome and prognostic factors in 100 cases of uterine sarcoma: experience in Helsinki University Central Hospital 1990-2001.
    Koivisto-Korander R; Butzow R; Koivisto AM; Leminen A
    Gynecol Oncol; 2008 Oct; 111(1):74-81. PubMed ID: 18657852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Real-World Study on Diagnosis and Treatment of Uterine Sarcoma in Western China.
    Li D; Yin N; Du G; Wang S; Xiao Z; Chen J; Chen W
    Int J Biol Sci; 2020; 16(3):388-395. PubMed ID: 32015676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical characteristics and prognosis analysis of uterine sarcoma: a single-institution retrospective study.
    Wang F; Dai X; Chen H; Hu X; Wang Y
    BMC Cancer; 2022 Oct; 22(1):1050. PubMed ID: 36207687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of lymphadenectomy in uterine leiomyosarcomas and endometrial stromal sarcomas: Systematic review and meta-analysis.
    Li Y; Gong Q; Peng J; Liu Y; Jiang Y; Zhang S
    Eur J Obstet Gynecol Reprod Biol; 2022 Dec; 279():94-101. PubMed ID: 36308940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current concepts in the imaging of uterine sarcoma.
    Tirumani SH; Ojili V; Shanbhogue AK; Fasih N; Ryan JG; Reinhold C
    Abdom Imaging; 2013 Apr; 38(2):397-411. PubMed ID: 22699695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. State of the science: Uterine sarcomas: From pathology to practice.
    Shushkevich A; Thaker PH; Littell RD; Shah NA; Chiang S; Thornton K; Hensley ML; Slomovitz BM; Holcomb KM; Leitao MM; Toboni MD; Powell MA; Levine DA; Dowdy SC; Klopp A; Brown J
    Gynecol Oncol; 2020 Oct; 159(1):3-7. PubMed ID: 32839026
    [No Abstract]   [Full Text] [Related]  

  • 18. Current status of the adjuvant therapy in uterine sarcoma: A literature review.
    Rizzo A; Pantaleo MA; Saponara M; Nannini M
    World J Clin Cases; 2019 Jul; 7(14):1753-1763. PubMed ID: 31417921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic therapy for endometrial stromal sarcomas: current treatment options.
    Serkies K; Pawłowska E; Jassem J
    Ginekol Pol; 2016; 87(8):594-7. PubMed ID: 27629136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uterine sarcomas and rare uterine mesenchymal tumors with malignant potential. Diagnostic guidelines of the French Sarcoma Group and the Rare Gynecological Tumors Group.
    Croce S; Devouassoux-Shisheboran M; Pautier P; Ray-Coquard I; Treilleux I; Neuville A; Arnould L; Just PA; Belda MALF; Averous G; Leroux A; Mery E; Loussouarn D; Weinbreck N; Le Guellec S; Mishellany F; Morice P; Guyon F; Genestie C
    Gynecol Oncol; 2022 Nov; 167(2):373-389. PubMed ID: 36114030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.